generic drugs

US importers report increased uncertainty due to new tariffs imposed by the Trump administration. Tariffs target 60 economies, some Canadian goods, generic drugs, and the EU, with unresolved questions about exemptions and interactions with ongoing investigations.

President Trump is imposing new tariffs on over 80 countries using Section 301 of the Trade Act of 1974 to combat forced labor and raise U.S. Treasury revenue. The tariffs range from 10% to 12.5%, and recent actions include 25% tariffs on Brazil, 50% on Canada, and up to 200% on generic drugs. The new tariffs are expected to face legal challenges.

President Trump imposes new tariffs on over 80 countries, ranging from 10% to 12.5%, using Section 301 of the Trade Act of 1974 to combat forced labor. The tariffs are expected to generate billions for the U.S. Treasury but may face federal court challenges.

President Trump is imposing new tariffs on over 80 countries using Section 301 of the Trade Act of 1974 to combat forced labor and raise U.S. Treasury revenue. Previous tariffs include 25% on Brazil, 50% on Canada, and up to 200% on generic drugs, with the new tariffs expected to raise billions and likely face federal court challenges.

The CEO of Indian pharma company Dr Reddy's warned that Trump's proposed tariffs on generic drugs will increase their prices in the U.S. for patients.

President Donald Trump plans to impose tariffs on imported generic drugs from India and China, effective August 1, 2026, with a zero percent tariff for two years. Patient advocates have expressed alarm over the proposal, which could block sourcing of generic medications.

President Trump announced 100 percent tariffs on imported generic drugs starting August 2028 unless manufacturers move production to the U.S., aiming to 'reshore' pharmaceutical production. The tariffs would penalize companies that do not comply with the production relocation requirement.

Trump plans to impose steep tariffs on generic drugs starting in 2028 as part of a phased schedule aimed at encouraging U.S. production. The goal is to push generic drug manufacturers to move their production onshore.

Donald Trump plans to impose 100% tariffs on generic drugs starting in 2028 as part of a trade measure aimed at encouraging companies to manufacture medications in the United States.

A settlement involving the Attorney General (AG) and generic drug companies was reported. The article was published on KSTP.com 5 Eyewitness News.

India's pharmaceutical industry produces 20% of the world’s generic drugs and supports global vaccine efforts, but faces vulnerabilities highlighted by a 2026 NITI Aayog report. The article questions the authenticity of 'Made in India' labels in the sector, suggesting reliance on Chinese manufacturing.

Generic drugs, which make up 90% of U.S. prescriptions, face quality issues leading to shortages, with over 60% of shortages due to quality concerns. Kevin Schulman, a Stanford professor, proposes FDA-encouraged independent lab testing to improve trust, citing Valisure's findings of impurities in medicines.